$NYMXF Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$NYMXF SEC Filings

Filing Filed On
FORM 6-K 20 May 2003
FORM 6-K 14 May 2003
FORM 6-K 31 Mar 2003
PROSPECTUS 24 Mar 2003
AMENDMENT NO. 6 TO FORM F-1, FILED ON FORM F-3 12 Mar 2003
6-K RPT. OF FOREIGN ISSUER 14 Nov 2002
SC 13G 26 Aug 2002
REPORT OF FOREIGN ISSUER 15 Aug 2002
FORM F-1 AMENDMENT NO. 5 30 Jul 2002
FORM 20-F AMENDMENT NO. 1 25 Jul 2002
FORM 20-F 27 Jun 2002
RPT OF FOREIGN ISSUER - NYMOX 15 May 2002
FORM 6-K 12 Apr 2002
FORM F-3 REGISTRATION STATEMENT 01 Apr 2002
POST EFFECTIVE AMENDMENT #4 09 Nov 2001
6-K REPORT OF FOREIGN ISSUER - NYMOX PHARM 09 Nov 2001
POST-EFFECTIVE AMENDMENT 3 - NYMOX PHARMACEUTICAL 10 Aug 2001
REPORT OF FOREIGN ISSUER - NYMOX PHARMACEUTICAL 09 Aug 2001
FORM 424B3 01 Jun 2001
POST EFFECTIVE AMENDMENT #2 15 May 2001